Cleared Traditional

K231870 - CASE V7.0 Cardiac Testing System and Ca...

K231870 is the FDA 510(k) clearance for CASE V7.0 Cardiac Testing System and Ca... by Ge Medical Systems Information Technologies, Inc.. It is a Class 2 Cardiovascular device (product code DQK) cleared through the Traditional 510(k) pathway after a 170-day FDA review.

K231870 · Ge Medical Systems Information Technologies, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2023
Decision
170d
Days
Class 2
Risk

K231870 is an FDA 510(k) clearance for the CASE V7.0 Cardiac Testing System and CardioSoft V7.0 Cardiac Testing System. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Ge Medical Systems Information Technologies, Inc. (Wauwatosa, US). The FDA issued a Cleared decision on December 13, 2023 after a review of 170 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Ge Medical Systems Information Technologies, Inc. devices

Submission Details

510(k) Number K231870 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 2023
Decision Date December 13, 2023
Days to Decision 170 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
45d slower than avg
Panel avg: 125d · This submission: 170d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 246
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K231870.
Merge Hemo, Model RCSV2
K233326 · Merge Healthcare Incorporated · Jun 2024
LumiGuide Wire
K233853 · Philips Medical Systems Nederland B.V. · Mar 2024
Affera Mapping System (AFR-00003)
K233943 · Medtronic, Inc. · Mar 2024
NeuTrace EP Mapping System v.2.1
K233160 · Anumana, Inc. · Nov 2023
HemoSphere Alta Advanced Monitoring Platform
K232294 · Edwards Lifesciences, LLC · Oct 2023
Volta AF-Xplorer
K232616 · Volta Medical · Sep 2023